Fostamatinib for the Treatment of Hospitalized Patients With COVID-19 Who Required Oxygen Supplementation: Results of a Phase 3 Trial
Gotur et al., Open Forum Infectious Diseases, doi:10.1093/ofid/ofad500.004
https://c19early.org/gotur.html